Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Cancer symbols : Vray save search
Military University Hospital Prague Selects ViewRay's MRIdian® MRI-Guided Radiation Therapy System to Treat Cancer Patients
Published: 2023-03-07 (Crawled : 12:00) - prnewswire.com
VRAY | $0.025 -39.9% -61.87% 110M
|
Health Technology
|
| O: 0.98%
H: 1.82%
C: -0.73%
mridian system military therapy cancer
Siteman Cancer Center at Washington University Treats 2,000th Patient with MRIdian® MRI-Guided Radiation Therapy
Published: 2023-03-02 (Crawled : 12:00) - prnewswire.com
VRAY | $0.025 -39.9% -61.87% 110M
|
Health Technology
|
| O: -1.15%
H: 1.17%
C: -0.93%
mridian therapy cancer
Findings Published in JAMA Oncology Demonstrate Superiority of MRIdian® MRI-Guidance in Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer
Published: 2023-01-12 (Crawled : 19:00) - biospace.com/
VRAY | $0.025 -39.9% -61.87% 110M
|
Health Technology
|
| O: 0.92%
H: 4.17%
C: 3.85%
mridian cancer prostate cancer
Chindex Medical Acquires 10 ViewRay MRIdian® Systems for Advanced Cancer Treatment
Published: 2023-01-05 (Crawled : 15:00) - prnewswire.com
VRAY | $0.025 -39.9% -61.87% 110M
|
Health Technology
|
| O: 0.7%
H: 15.35%
C: 7.91%
mridian treatment viewray medical cancer
MIRAGE Phase III Randomized Controlled Trial Demonstrates Superiority of MRIdian® MRI-Guidance in Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer
Published: 2022-10-27 (Crawled : 11:00) - prnewswire.com
VRAY | $0.025 -39.9% -61.87% 110M
|
Health Technology
|
| O: 2.34%
H: 0.23%
C: -4.79%
mridian trial cancer prostate cancer
ViewRay Announces Primary Endpoint Outcome from First Prospective, Multi-Institutional Study to Deliver Ablative Doses of Radiation to Pancreatic Cancer Patients
Published: 2022-10-24 (Crawled : 11:00) - prnewswire.com
VRAY | $0.025 -39.9% -61.87% 110M
|
Health Technology
|
| O: 1.78%
H: 6.0%
C: 4.0%
GRTX | $0.1989 0.25% 2.2M
|
Health Technology
|
| O: 3.59%
H: 0.0%
C: -0.58%
viewray cancer study pancreatic
Growing Awareness of the Benefits of Radiotherapy and the Increasing Use of Particle Therapy for Cancer Treatment is expected to Drive the Global Radiation Therapy Market | UnivDatos Market Insights
Published: 2022-10-18 (Crawled : 15:00) - prnewswire.com
VRAY | $0.025 -39.9% -61.87% 110M
|
Health Technology
|
| O: 3.15%
H: 1.78%
C: 0.76%
ARAY | News | $2.225 1.6% 170K
|
Health Technology
|
| O: 2.02%
H: 1.24%
C: -3.96%
treatment global growing expected therapy cancer benefits market
ViewRay Launches Phase III Pancreatic Cancer Study to Demonstrate Superior Overall Survival for Patients Receiving MRI-guided Ablative Radiation Therapy
Published: 2022-10-18 (Crawled : 11:00) - prnewswire.com
VRAY | $0.025 -39.9% -61.87% 110M
|
Health Technology
|
| O: 3.15%
H: 1.78%
C: 0.76%
viewray therapy cancer study pancreatic
SUNY Upstate Cancer Center Chooses ViewRay's MRI-Guided Radiation Therapy System to Treat Cancer Patients
Published: 2022-10-06 (Crawled : 11:00) - prnewswire.com
VRAY | $0.025 -39.9% -61.87% 110M
|
Health Technology
|
| O: 1.57%
H: 1.68%
C: -0.26%
system therapy cancer
MD Anderson Cancer Center Selects ViewRay to Expand MR-Guided Radiation Therapy Program
Published: 2022-09-20 (Crawled : 11:00) - prnewswire.com
MS | News 0 d | $90.84 0.84% 900K
|
Finance
|
| O: -0.7%
H: 0.4%
C: -1.03%
VRAY | $0.025 -39.9% -61.87% 110M
|
Health Technology
|
| O: -0.27%
H: 12.47%
C: 8.77%
viewray program therapy cancer
ViewRay Announces China NMPA Approval of its MRIdian® MRI-Guided Radiation Therapy for Cancer Patients
Published: 2022-09-07 (Crawled : 11:00) - prnewswire.com
VRAY | $0.025 -39.9% -61.87% 110M
|
Health Technology
|
| O: 3.69%
H: 3.26%
C: 3.26%
mridian viewray approval china therapy cancer
National Cancer Center Hospital in Tokyo Upgrades to MRIdian® Linac for MRI-Guided Radiation Therapy and has treated its first patients
Published: 2022-08-11 (Crawled : 11:00) - prnewswire.com
VRAY | $0.025 -39.9% -61.87% 110M
|
Health Technology
|
| O: 1.44%
H: 3.41%
C: 1.42%
mridian therapy cancer
First Toxicity Results from SCIMITAR Prospective Phase II Trial Signal Favorable Toxicity Profile of Post-Prostatectomy Stereotactic Body Radiotherapy (SBRT) for Prostate Cancer
Published: 2022-03-10 (Crawled : 12:00) - prnewswire.com
VRAY | $0.025 -39.9% -61.87% 110M
|
Health Technology
|
| O: 1.01%
H: 0.5%
C: -1.75%
prostate cancer pos state trial therapy results cancer iot
Interim Findings from MIRAGE Phase III Randomized Trial Signal Superiority of MRIdian® MRI-guidance in Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer
Published: 2022-02-15 (Crawled : 12:00) - prnewswire.com
VRAY | $0.025 -39.9% -61.87% 110M
|
Health Technology
|
| O: 3.4%
H: 1.1%
C: -7.24%
mridian prostate cancer state trial therapy cancer iot
ViewRay Announces MRIdian MR-Guided Radiation Therapy Surpasses 2,300 Pancreatic Cancer Patients Treated Worldwide
Published: 2021-11-24 (Crawled : 13:30) - biospace.com/
VRAY | $0.025 -39.9% -61.87% 110M
|
Health Technology
|
| O: -0.54%
H: 6.2%
C: 5.47%
therapy cancer radiation therapy pancreatic
New Outcomes Data Demonstrating Prolonged Survival for Inoperable Pancreatic Cancer Patients Presented at Leading Radiation Oncology Meeting
Published: 2021-10-28 (Crawled : 12:00) - biospace.com/
VRAY | $0.025 -39.9% -61.87% 110M
|
Health Technology
|
| O: 1.47%
H: 4.05%
C: 3.32%
cancer pancreatic pancreas
Helsinki University Hospital Selects MRIdian® System for Installation at Comprehensive Cancer Center
Published: 2021-10-25 (Crawled : 11:00) - prnewswire.com
VRAY | $0.025 -39.9% -61.87% 110M
|
Health Technology
|
| O: 1.48%
H: 4.31%
C: 2.19%
cancer
Global Radiation Oncology Markets, 2021-2028 - Increasing Application Of Radiopharmaceuticals, Rising Prevalence Of Cancer, & Rising Adoption Of Radiotherapy
Published: 2021-10-22 (Crawled : 19:00) - prnewswire.com
ARAY | News | $2.225 1.6% 170K
|
Health Technology
| Email alert
Add to watchlist
VRAY | $0.025 -39.9% -61.87% 110M
|
Health Technology
| Email alert
Add to watchlist
application therapy cancer iot
Radiotherapy Market Size to Reach USD 7.65 Billion in 2027 | Increasing Global Incidence of Cancer, Rising Use of Radiotherapy in Combination with Other Treatment Approaches are Some Key Factors Driving Industry Demand, says Emergen Research
Published: 2021-08-11 (Crawled : 14:15) - prnewswire.com
VRAY | $0.025 -39.9% -61.87% 110M
|
Health Technology
|
| O: 0.0%
H: 0.67%
C: -4.88%
ARAY | News | $2.225 1.6% 170K
|
Health Technology
|
| O: -0.5%
H: 0.0%
C: -1.0%
treatment therapy cancer research iot merge
Miami Cancer Institute Enrolls First Patients in Single-Fraction Stereotactic MRI-Guided Adaptive Radiation Therapy for Inoperable Primary or Metastatic Cancer Trial
Published: 2021-07-07 (Crawled : 11:00) - prnewswire.com
VRAY | $0.025 -39.9% -61.87% 110M
|
Health Technology
|
| O: 1.96%
H: 1.63%
C: -1.63%
therapy cancer radiation therapy trial enroll
Gainers vs Losers
| 77% | 23% |
Top 10 Gainers
TIRX | $1.13 133.09% 44M
|
AGBA | $0.8978 124.45% 60M
|
Finance
BPTH | $6.18 90.74% 39M
|
Health Technology
INVO | $1.44 89.47% 3M
|
Health Technology
SINT | $0.0588 57.64% 240M
|
Health Technology
XPON | $2.66 37.82% 5.2M
|
THCH | $1.38 32.69% 9.9M
|
n/a
ALRN | $5.605 31.88% 210K
|
Health Technology
HOLO | $2.92 30.36% 22M
|
VTNR S | $1.25 27.66% 3.2M
|
Industrial Services
Your saved searches
Save your searches and get alerts when important news are released.